KIAA1524: A novel MLL translocation partner in acute myeloid leukemia

Eva A. Coenen, C. Michel Zwaan, Claus Meyer, Rolf Marschalek, Rob Pieters, Lars T. van der Veken, H. Berna Beverloo, Marry M. Van den Heuvel-Eibrink*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

14 Citations (Scopus)

Abstract

The Mixed Lineage Leukemia gene on chromosome 11q23 is a frequent site of recurrent translocations in acute leukemias. Its promiscuous character is reflected by the more than 60 different translocation partners described in literature. Prompted by karyotype and atypical FISH results, we identified a new translocation partner in infant acute myeloid leukemia, KIAA1524 on 3q13.13, also known as 'Cancerous Inhibitor of Protein phosphatase 2A (CIP2A)'. This gene was recently identified as a proto-oncogene stabilizing MYC protein in gastric carcinoma. KIAA1524 has never been related to hematologic malignancies before, and the current AML case is the first case in which an MLL-KIAA1524 fusion was described.

Original languageEnglish
Pages (from-to)133-135
Number of pages3
JournalLeukemia Research
Volume35
Issue number1
DOIs
Publication statusPublished - 1 Jan 2011

Keywords

  • Acute myeloid leukemia
  • CIP2A
  • KIAA1524
  • MLL

Fingerprint

Dive into the research topics of 'KIAA1524: A novel MLL translocation partner in acute myeloid leukemia'. Together they form a unique fingerprint.

Cite this